Alnylam Pharmaceuticals reported $1.21M in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31247M 849M
Arrowhead Research ARWR:US $ 198K 1000
Avrobio Inc AVRO:US $ 4K 0
Biocryst Pharmaceuticals BCRX:US $ 1.86M 0.01M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.71M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Moderna Inc MRNA:US 40K 40K
Novartis NVS:US $ 901M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Regulus Therapeutics RGLS:US $ 0.15M 0M
Sangamo Biosciences SGMO:US $ 1.47M 0.01M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Takeda 4502:JP Y 1676263M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M
Xencor XNCR:US $ 0.6M 0M
YTE INCY:US $ 0.22M 0M